Published in J Urol on January 15, 2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2012) 2.95
National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses. Urology (2013) 2.28
Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology (2013) 1.49
Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer. Cancer (2014) 1.40
Patient safety and the diffusion of surgical innovations: a national analysis of laparoscopic partial nephrectomy. Surg Endosc (2012) 0.99
Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. J Urol (2013) 0.93
Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study. World J Urol (2016) 0.87
Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World J Urol (2012) 0.83
The Effect of the Diffusion of the Surgical Robot on the Hospital-level Utilization of Partial Nephrectomy. Med Care (2015) 0.81
Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies. World J Urol (2014) 0.81
The use of partial nephrectomy: results from a contemporary national prospective multicenter study. World J Urol (2014) 0.80
A population-based study of surgeon characteristics associated with the uptake of contemporary techniques in renal surgery. Can Urol Assoc J (2013) 0.79
Predicting outcomes in partial nephrectomy: is the renal score useful? Int Braz J Urol (2017) 0.78
Defining the level of evidence for technology adoption in the localized prostate cancer pathway. Urol Oncol (2013) 0.77
Open Partial Nephrectomy for High-Risk Renal Masses Is Associated with Renal Pseudoaneurysms: Assessment of a Severe Procedure-Related Complication. Biomed Res Int (2015) 0.75
Limited use of surveillance imaging following nephrectomy for renal cell carcinoma. Urol Oncol (2015) 0.75
Renal cell carcinoma: Are we attacking a different tumor over the past 10 years? Int J Health Sci (Qassim) (2016) 0.75
Kidney cancer: assessing the management of localized kidney cancer. Nat Rev Urol (2012) 0.75
Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States. Urol Oncol (2016) 0.75
Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? Urology (2016) 0.75
The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses. Korean J Urol (2014) 0.75
A novel method for texture-mapping conoscopic surfaces for minimally invasive image-guided kidney surgery. Int J Comput Assist Radiol Surg (2016) 0.75
Solidifying prognosis after surgery for renal cell carcinoma. Can Urol Assoc J (2014) 0.75
American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy. World J Urol (2016) 0.75
Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent. PLoS One (2017) 0.75
Wide range and variation in minimally invasive surgery for renal malignancy in Japan: a population-based analysis. Int J Clin Oncol (2012) 0.75
Is there a volume-outcome relationship for partial nephrectomy? World J Urol (2013) 0.75
Trends in the Management of Small Renal Masses: A Survey of Members of the Endourological Society. J Kidney Cancer VHL (2017) 0.75
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med (2010) 29.75
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst (2002) 9.45
Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14
Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med (2013) 7.95
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst (2004) 5.84
Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst (2005) 5.10
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol (2007) 5.03
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01
Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst (2013) 3.81
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol (2012) 3.30
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol (2007) 3.26
Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. J Natl Cancer Inst (2010) 3.24
Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int (2012) 2.88
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol (2013) 2.76
Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control (2007) 2.69
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer (2012) 2.61
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol (2011) 2.51
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol (2010) 2.39
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis. BJU Int (2012) 2.37
Castration-resistant prostate cancer: AUA Guideline. J Urol (2013) 2.36
Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Neurourol Urodyn (2012) 2.35
NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw (2010) 2.31
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer Epidemiol Biomarkers Prev (2011) 2.25
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol (2007) 2.24
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. J Urol (2005) 2.24
Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol (2007) 2.20
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol (2012) 2.19
Access to information sources and treatment considerations among men with local stage prostate cancer. Urology (2009) 2.15
Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Med Decis Making (2008) 2.06
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol (2010) 2.03
What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol (2008) 2.02
Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups. J Urol (2012) 1.98
Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol (2005) 1.97
Robotic-assisted laparoscopic prostatectomy: what is the learning curve? Urology (2005) 1.93
Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol (2005) 1.89
Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol (2006) 1.88
Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol (2002) 1.87
Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol (2012) 1.85
Volume outcomes of cystectomy--is it the surgeon or the setting? J Urol (2012) 1.77
Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med (2011) 1.76
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol (2007) 1.76
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol (2007) 1.75
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol (2007) 1.74
Urinary diversion trends at a high volume, single American tertiary care center. J Urol (2009) 1.73
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol (2011) 1.72